8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-benzo(c)(1)oxacyclotetradecine-1,7(8H)-dione,
f152A1 compound,
FR 148083,
FR-148083,
FR148083,
LL Z1640-2,
LL-Z1640-2,
CHEBI:67558,
(5E)-7-Oxozeaenol,
CHEMBL1801950,
LL-Z-1640-2,
253863-19-3,
Cochliomycin F,
LL Z1640-2,
5E-7-oxozeaenol,
SCHEMBL3841564,
SCHEMBL18290352,
ZX-AFC000514,
66018-38-0,
BDBM50129126,
MFCD00932468,
AKOS024457711,
ZINC100091176,
(2E,5S,6S,8E,11S)-5,6,15-trihydroxy-17-methoxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(18),2,8,14,16-pentaene-7,13-dione,
(3S,5E,8S,9S,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione,
(3S,5Z,8S,9S,11E)-3,4,9,10-tetrahydro-8,9,16-trihydroxy-14-methoxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione,
(5Z)-7-Oxozeaenol,
CID9799061,
LL-Z1640-1,
CID 9799061,